Accumulating evidence suggests that ROCK1/2 upregulation contributes to the malignancy of breast, pancreatic, colorectal, and liver cancer through various signaling factors, including STAT3 and myosin light chain phosphatase 1 (MYPT1), thereby promoting cancer invasion and metastasis [6]. Here, STAT3 is linked to cancer.